A significant (p < 0.05) positive correlation was also observed between ESR1 and IRF6 gene expression levels in Basal and Luminal A breast cancer patients, and there was also a significant (p < 0.05) positive correlation between ESR1 and NFIL3 gene expression levels in Basal breast cancer patients. Here, IRF6 is linked to breast carcinoma.